scispace - formally typeset
A

Abraham Vaisberg

Researcher at Cayetano Heredia University

Publications -  76
Citations -  2855

Abraham Vaisberg is an academic researcher from Cayetano Heredia University. The author has contributed to research in topics: Measles & Internal medicine. The author has an hindex of 29, co-authored 69 publications receiving 2630 citations. Previous affiliations of Abraham Vaisberg include University of Louisville & Institut de recherche pour le développement.

Papers
More filters
Journal ArticleDOI

Ethnobotany, phytochemistry and pharmacology of Uncaria (Rubiaceae).

TL;DR: The Uncaria genus is an important source of medicinal natural products, particularly alkaloids and triterpenes as discussed by the authors, and the most recent developments in the ethnobotany, pharmacology and phytochemistry of this genus are covered in this review.
Journal ArticleDOI

Evaluation of the wound-healing activity of selected traditional medicinal plants from Perú

TL;DR: Extracts from Peperomia galioides and Anredera diffusa had no effect on cell proliferation and did not exhibit mutagenic activity, and significant wound-healing activity was detected in Peperomegalioides, AnredERA diffusa and Jatropha curcas.
Journal ArticleDOI

Immune Activation in Measles

TL;DR: The proliferative phase of the immune response, as measured by the release of soluble interleukin-2 receptor, begins before the rash appears, continues for several weeks in those without complications, but does not occur within the nervous system during encephalomyelitis.
Journal ArticleDOI

Cellular immune responses during complicated and uncomplicated measles virus infections of man.

TL;DR: Three studies indicate varied disruptions of immune reactivity during measles, with lymphocyte responses to measles antigen and PPD demonstrated in patients with encephalitis and uncomplicated disease, even early in infection.
Journal ArticleDOI

Synthesis, Cytotoxicity, and Anti-Trypanosoma cruzi Activity of New Chalcones

TL;DR: Synthesis of a cytotoxic dihydrochalcone, first isolated from a traditional Amazonian medicinal plant, and a comprehensive SAR analysis of saturated and unsaturated chalcone synthetic intermediates led to the identification of analogues with selective and significant in vitro anti- Trypanosoma cruzi activity.